Brief: CVS Says CVS Caremark To Add Zepbound To Commercial Formularies As Additional Preferred Option On Oct 1
BRIEF-CVS Says CVS Caremark To Add Zepbound To Commercial Formularies As Additional Preferred Option On Oct 1 May 28 (Reuters) - CVS Health Corp CVS.N:
CVS CAREMARK DELIVERS AFFORDABILITY AND ACCESS TO GLP-1 WEIGHT MANAGEMENT MEDICATIONS WITH EXPANDED COVERAGE OPTIONS
CVS HEALTH: CVS CAREMARK TO REMOVE NEW-TO-MARKET BLOCK ON FOUNDAYO EFFECTIVE JUNE 1
CVS HEALTH: CVS CAREMARK TO ADD ZEPBOUND TO COMMERCIAL FORMULARIES AS ADDITIONAL PREFERRED OPTION ON OCT 1
((Reuters.Briefs@thomsonreuters.com))
Recent news on Eli Lilly and Co
See all newsAntares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Absci rises on positive hair-loss drug data
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says
HK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)